ID: ALA1789829

Max Phase: Preclinical

Molecular Formula: C12H19N3O2

Molecular Weight: 237.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NCCC1CC1)OCCCc1c[nH]cn1

Standard InChI:  InChI=1S/C12H19N3O2/c16-12(14-6-5-10-3-4-10)17-7-1-2-11-8-13-9-15-11/h8-10H,1-7H2,(H,13,15)(H,14,16)

Standard InChI Key:  ZMYWSFVTVVHGEG-UHFFFAOYSA-N

Associated Targets(Human)

Histamine H4 receptor 3997 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Histamine H3 receptor 10389 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Histamine H2 receptor 1693 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Histamine H1 receptor 2054 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 237.30Molecular Weight (Monoisotopic): 237.1477AlogP: 1.87#Rotatable Bonds: 7
Polar Surface Area: 67.01Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.12CX Basic pKa: 6.57CX LogP: 1.17CX LogD: 1.12
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.71Np Likeness Score: -0.52

References

1. Sadek B, Shehab S, Więcek M, Subramanian D, Shafiullah M, Kieć-Kononowicz K, Adem A..  (2013)  Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanol.,  23  (17): [PMID:23891186] [10.1016/j.bmcl.2013.06.075]

Source